NCT00001381View on ClinicalTrials.gov

A Phase I Trial Using Suramin to Treat Superficial Transitional Cell Carcinoma of the Bladder

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

March 31, 1994

Study Completion Date

December 31, 2000

Conditions
Bladder NeoplasmsCarcinoma, Transitional Cell
Interventions
DRUG

suramin

Trial Locations (1)

20892

National Cancer Institute (NCI), Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00001381 - A Phase I Trial Using Suramin to Treat Superficial Transitional Cell Carcinoma of the Bladder | Biotech Hunter | Biotech Hunter